EHFG
Recordings overview

S5 - Pioneering cross-border collaborations for the European Health Union

Learnings from Childhood cancer successes

Session description

The paediatric cancer sector in Europe is unique: due to the rarity of individual paediatric cancer types, there is a long-standing history of cross-border collaboration on research and healthcare delivery.In this session, healthcare professionals and civil society representatives will share how European cooperation across childhood cancer has developed, highlighting different concepts and structures leading to success. The panel will examine responses to medicine shortages and lack of essential medicines in Europe.Panellists will reflect on collaborative approaches aimed at tackling the challenges of the field such as European Reference Networks and innovative digital solutions. Attendees will be encouraged to explore and discuss anticipated changes of the Revision of the EU Pharmaceutical Strategy and establish how the childhood cancer community can offer a blueprint for cross-border collaboration in the European Health Union.

Speakers in this session

Vassal, Gilles
Vassal, GillesEuropean Society for Paediatric Oncology
Tamas, Alexandra
Tamas, AlexandraEuropean Federation of Pharmaceutical Industries & Associations
Kameric, Lejla
Kameric, LejlaChildhood Cancer International - Europe
Ujhelyi, Istvan
Ujhelyi, IstvanEuropean Parliament
Ladenstein, Ruth
Ladenstein, RuthHead of the Clinical Trials Unit S²IRP - CCRI (Studies & Statistics for Integrated Research and Projects) St. Anna Kinderkrebsforschung e.V.